Axon Enterprise Inc. has announced it has entered into privately negotiated exchange agreements with certain holders of its 0.50% convertible senior notes due 2027. Under these agreements, Axon will exchange approximately $177.9 million in aggregate principal amount of notes for a combination of cash and unregistered shares of its common stock. The number of shares to be issued will be determined based on the volume-weighted average price of the stock during a specified trading period, with an estimated 468,000 shares expected to be issued. The transaction is expected to close on or about December 16, 2025, after which around $100.1 million in principal amount of the notes will remain outstanding. The shares will be issued pursuant to an exemption from SEC registration requirements, limited to institutional accredited investors and qualified institutional buyers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AXON Enterprise Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-056229), on December 10, 2025, and is solely responsible for the information contained therein.
Comments